文献速递青光眼白内障与屈光手术

超声乳化联合房角分离及Kahook双刃刀内路小梁切除术治疗闭角型青光眼合并白内障的临床疗效

[Clinical efficacy of combined phacoemulsification and goniosynechialysis with Kahook double-blade goniotomy for treatment of angle-closure glaucoma].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2026-01-01

前瞻性非随机病例对照研究纳入101例(116只眼)原发性闭角型青光眼合并白内障患者,比较Phaco-GSL与Phaco-GSL联合Kahook双刃刀内路小梁切除术(Phaco-GSL-KDB)的疗效与安全性。术后12个月Phaco-GSL-KDB组眼压下降幅度为47.60%、条件成功率达91.8%,均优于Phaco-GSL组,两组均未出现严重并发症。

要点

  • Phaco-GSL-KDB组术后12个月眼压下降幅度为47.60%,高于Phaco-GSL组的38.01%。
  • 术后12个月眼压≤18 mmHg条件成功率Phaco-GSL-KDB组为91.8%,Phaco-GSL组为70.9%。
  • Phaco-GSL-KDB组抗青光眼药物从术前3.00(2.00,3.00)个减少至1.00(0.00,1.00)个。

核心结论

  • 在本研究中,Phaco-GSL-KDB治疗原发性闭角型青光眼合并白内障的降眼压效果优于Phaco-GSL。
  • 两种联合手术方式均可减少术后抗青光眼药物使用数量并改善视野,具有良好的治疗有效性和安全性。
  • 两组术后均未出现严重手术并发症。

研究设计与样本

  • 前瞻性非随机病例对照研究,纳入2023年3月至2024年12月山东第一医科大学附属眼科医院拟行白内障摘除联合抗青光眼手术的PACG-C患者。
  • 共纳入101例(116只眼),男性32例(34.81%),女性69例(65.19%),年龄为(67.28±7.07)岁。
  • Phaco-GSL-KDB组56例(61只眼),Phaco-GSL组45例(55只眼),根据病情程度分组。
  • 记录并比较术前及术后1 d、1周、1个月、3个月、6个月及12个月的视力、眼压、抗青光眼药物使用数量、视野及手术成功率。
  • 采用配对t检验、Wilcoxon符号秩检验、独立样本t检验、Mann-Whitney U检验、卡方检验、Friedman检验进行统计学分析。

主要发现

  • 术前Phaco-GSL-KDB组抗青光眼药物种类数量为3.00(2.00,3.00)个,多于Phaco-GSL组的2.00(1.00,3.00)个(P<0.05)。
  • 术前Phaco-GSL-KDB组视野平均偏差为-23.68(-28.90,-12.81)dB,低于Phaco-GSL组的-12.96(-23.18,-5.27)dB(P<0.05)。
  • 两组年龄、视力、眼压等基线参数差异均无统计学意义(均P>0.05)。
  • 术后随访12个月,两组视力均较术前提高(均P<0.05),两组术后眼压均较术前降低。
  • Phaco-GSL-KDB组各随访时间眼压均低于Phaco-GSL组,术后12个月眼压下降幅度分别为47.60%和38.01%(均P<0.05)。

关键数值与推荐

  • 条件成功率定义为术后12个月眼压≤18 mmHg(1 mmHg=0.133 kPa)。
  • 术后12个月条件成功率Phaco-GSL-KDB组为91.8%,Phaco-GSL组为70.9%。
  • Phaco-GSL-KDB组抗青光眼药物种类数量从术前3.00(2.00,3.00)个减少为1.00(0.00,1.00)个,优于Phaco-GSL组(P<0.05)。

临床怎么用

  • 对于原发性闭角型青光眼合并白内障患者,可考虑Phaco-GSL联合KDB内路小梁切除术以增强降眼压效果。
  • 联合KDB术式可能有助于减少术后抗青光眼药物使用数量并提高手术成功率。
  • 两种联合术式均可改善视野,术前需结合病情程度个体化选择术式。

局限性

  • 本研究为非随机病例对照研究,分组依据病情程度,可能存在选择偏倚。
  • 两组术前抗青光眼药物数量和视野平均偏差存在显著差异,基线不完全均衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare the clinical efficacy and safety of phacoemulsification with goniosynechialysis (Phaco-GSL) versus Phaco-GSL combined with excisional goniotomy using the Kahook dual blade (KDB) in the treatment of primary angle-closure glaucoma with cataract (PACG-C). Methods: A prospective non-randomized case-control study was conducted. Patients with PACG-C scheduled for combined cataract extraction and anti-glaucoma surgery at the Eye Hospital of Shandong First Medical University from March 2023 to December 2024 were enrolled. Based on the disease severity, they were assigned to either the Phaco-GSL-KDB group or the Phaco-GSL group for the corresponding surgical procedure. The visual acuity, intraocular pressure (IOP), number of anti-glaucoma medications used, visual field, and surgical success rate were recorded and compared between the two groups preoperatively, at 1 day, 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively. The paired t-test, Wilcoxon signed-rank test, independent samples t-test, Mann-Whitney U test, Chi-square test, and Friedman test were employed for statistical analysis. Results: A total of 101 patients (116 eyes) with PACG-C who met the inclusion criteria were enrolled, including 32 males (34.81%) and 69 females (65.19%), with a mean age of (67.28±7.07) years. There were 56 patients (61 eyes) in the Phaco-GSL-KDB group and 45 patients (55 eyes) in the Phaco-GSL group. In the Phaco-GSL-KDB group, the number of preoperative anti-glaucoma medications was higher than that in the Phaco-GSL group [3.00 (2.00, 3.00) vs. 2.00 (1.00, 3.00)], while the mean deviation was lower [-23.68 (-28.90, -12.81) dB vs.-12.96 (-23.18, -5.27) dB], with differences being statistically significant (both P<0.05). There were no statistically significant differences between the two groups in baseline parameters such as age, visual acuity, and IOP (all P>0.05). At the 12-month follow-up, the visual acuity improved in both groups compared to preoperative levels (both P<0.05). The IOP decreased in both groups compared to preoperative levels, and the Phaco-GSL-KDB group maintained lower IOP than the Phaco-GSL group at all follow-up time points. At 12 months postoperatively, the reduction in IOP was 47.60% in the Phaco-GSL-KDB group vs. 38.01% in the Phaco-GSL group (both P<0.05). The mean deviation improved, and the pattern standard deviation (PSD) decreased in both groups (all P<0.05). The reduction in PSD in the Phaco-GSL-KDB group was 2.8%. Both the complete success rate and conditional success rate were higher in the Phaco-GSL-KDB group compared to the Phaco-GSL group (both P<0.05). Specifically, the conditional success rate [defined as IOP≤18 mmHg (1 mmHg=0.133 kPa) at 12 months postoperatively] was 91.8% in the Phaco-GSL-KDB group and 70.9% in the Phaco-GSL group. The number of anti-glaucoma medications decreased postoperatively in both groups compared to preoperative levels (both P<0.05). In the Phaco-GSL-KDB group, the number decreased from 3.00 (2.00, 3.00) preoperatively to 1.00 (0.00, 1.00), which was superior to the Phaco-GSL group (P<0.05). No serious postoperative complications occurred in either group. Conclusions: Phaco-GSL-KDB demonstrated superior IOP-lowering efficacy compared to Phaco-GSL in the treatment of PACG. Both combined surgical approaches effectively reduced the number of postoperative anti-glaucoma medications and improved the visual field, indicating favorable therapeutic effectiveness and safety. 目的: 探讨超声乳化白内障吸除及房角分离术(Phaco-GSL)联合Kahook双刃刀(KDB)内路小梁切除术(Phaco-GSL-KDB)治疗原发性闭角型青光眼合并白内障(PACG-C)的临床疗效及安全性。 方法: 前瞻性非随机病例对照研究。将2023年3月至2024年12月就诊于山东第一医科大学附属眼科医院拟行白内障摘除联合抗青光眼手术的PACG-C患者,根据病情程度分为Phaco-GSL-KDB组和Phaco-GSL组行手术治疗,记录并比较两组患者术前及术后1 d、1周、1个月、3个月、6个月及12个月的视力、眼压、抗青光眼药物使用数量、视野及手术成功率等。采用配对t检验、Wilcoxon符号秩检验、独立样本t检验、Mann-Whitney U检验、卡方检验、Friedman检验进行统计学分析。 结果: 纳入符合标准的PACG-C患者101例(116只眼),男性32例(34.81%),女性69例(65.19%),年龄为(67.28±7.07)岁;Phaco-GSL组45例(55只眼),Phaco-GSL-KDB组56例(61只眼)。术前Phaco-GSL-KDB组使用抗青光眼药物种类的数量[3.00(2.00,3.00)个]多于Phaco-GSL组[2.00(1.00,3.00)个],而视野平均偏差[-23.68(-28.90,-12.81)dB]低于Phaco-GSL组[-12.96(-23.18,-5.27)dB],差异均有统计学意义(均P<0.05);两组年龄、视力、眼压等基线参数差异均无统计学意义(均P>0.05)。术后随访12个月,两组术后视力均较术前提高(均P<0.05)。两组术后眼压均较术前降低,且Phaco-GSL-KDB组各随访时间眼压均低于Phaco-GSL组,术后12个月Phaco-GSL-KDB组眼压的下降幅度为47.60%,Phaco-GSL组为38.01%,差异均有统计学意义(均P<0.05)。两组术后视野平均偏差和模式标准差均较术前改善,差异均有统计学意义(均P<0.05),Phaco-GSL-KDB组的模式标准差改善幅度为2.8%。Phaco-GSL-KDB组的手术完全成功率和条件成功率均优于Phaco-GSL组(均P<0.05),其中术后12个月眼压≤18 mmHg(1 mmHg=0.133 kPa)条件成功率Phaco-GSL-KDB组达到91.8%,Phaco-GSL组为70.9%。两组术后使用抗青光眼药物种类数量均较术前减少(均P<0.05),Phaco-GSL-KDB组从术前3.00(2.00,3.00)个减少为1.00(0.00,1.00)个,优于Phaco-GSL组(P<0.05)。两组术后均未出现严重手术并发症。 结论: 在本研究中,Phaco-GSL-KDB治疗PACG的降眼压效果优于Phaco-GSL,且两种联合手术方式均可减少术后抗青光眼药物使用种类的数量,改善患者视野,具有良好的治疗有效性和安全性。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang S, Zhao C, Niu MD, et al. [Clinical efficacy of combined phacoemulsification and goniosynechialysis with Kahook double-blade goniotomy for treatment of angle-closure glaucoma]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 42252231. doi:10.3760/cma.j.cn112142-20260120-00023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。